Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Acibadem buys 80% stake in Bayindir Hospitals

The largest private hospital group in Turkey, Acibadem, has acquired an 80% stake in Bayindir Hospitals, another hospital group in Turkey, from lender İş Bankası, for $55 million, valuing the business at ~$80 million, according to Chairman Mehmet Ali Aydınlar. İş Bankası will own the remaining 20% share. The deal includes three hospitals and six dental clinics under the Bayındır Health Group, including two in Ankara and one in Istanbul, with 1,252 employees, including 205 physicians. 

Evernow and Oura Ring partner to provide personalised menopause care

Investor interest is surging in women’s health tech, with wearables like Oura Ring and Whoop attracting hundreds of millions in funding. These devices give personalised insights into menstrual, reproductive, and menopausal health, highlighting a rapidly expanding market long overlooked by traditional healthcare.

Investing in Europe’s healthcare energy transition – interview with Andrey Maramzine, Chief Sustainability Officer, BNP Paribas Leasing Solutions

BNP Paribas Leasing Solutions, a fully owned subsidiary of the BNP Paribas Group, France-based second largest bank in Europe, offers green finance for hospital decarbonisation through sustainability-linked loans, green bonds, and leasing. In 2024, the bank arranged a €1.45 billion sustainability-linked loan for Ramsay Santé. It also invests in nearly 80 ESG-focused healthcare properties. HBI spoke with Maramzine to learn more about the PaaS model and explore the investment opportunities in Europe’s green healthcare infrastructure.

Alcon to acquire STAAR Surgical for US $1.5bn

Alcon’s planned purchase of STAAR Surgical adds the latter’s EVO ICL lens technology to its refractive surgery portfolio, aiming to broaden treatment options for myopia and strengthen its position in a market seeing significant deal activity.

France targets PE-owned medical labs with profit caps

Despite upcoming profit caps and tighter regulations, France’s medical laboratory sector remains large and resilient. It still offers opportunities for investors in regional and tech-driven labs able to navigate tighter margins.

Find Us